Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study

Dominique Farge, Séverine Loisel, Matthieu Resche‐Rigon, Pauline Lansiaux, Inés Colmegna, David Langlais, Catney Charles, G. Pugnet, A. Maria, Emmanuel Chatelus, Thierry Martin, É. Hachulla, Vissal David Kheav, Nathalie Lambert, HanChen Wang, David Michonneau, Christophe Martinaud, Luc Sensebé, Audrey Cras, Karin Tarte